This was confirmed in our in vivo experiments in which BTN3A1 increased the proportion of CD4+ T cells (including a higher percentage of Th1, Th2, Th17 cells and a lower percentage of Treg cells) in the lupus‐like mice. Here, BTN3A1 is linked to systemic lupus erythematosus.